A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Clinical trial NCT06364904 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06364904
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-04-15
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.